Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-01-23 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
深圳普门科技股份有限公司第三届监事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Shenzhen Pumen Technology Co., Ltd. regarding the cancellation of reserved stock options under the 2021 stock option incentive plan. It includes details about the meeting, voting results, and legal compliance statements. The document is short (835 characters) and primarily announces a board decision rather than providing detailed financial data or a full report. It does not contain financial statements or comprehensive analysis. It is not an annual or interim report, audit report, or earnings release. It is also not a regulatory filing or certification letter. The content fits best under Board/Management Information (MANG) as it relates to a board resolution and management decision on stock options.
2024-01-23 Chinese
深圳普门科技股份有限公司监事会对注销2021年股票期权激励计划预留授予部分股票期权的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board's verification opinion on the cancellation of reserved stock options under the 2021 stock option incentive plan. It discusses compliance with relevant laws and regulations, the number of stock options canceled, and the impact on the company and shareholders. The document is short (993 characters) and focuses on a specific corporate governance action related to stock options, not a full financial report or earnings release. It is not an announcement of a report publication but a formal opinion or statement regarding stock option cancellation. This fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other specific categories like capital changes or remuneration reports.
2024-01-23 Chinese
深圳普门科技股份有限公司关于自愿披露控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shenzhen Pumen Technology Co., Ltd. regarding the voluntary disclosure of its controlling subsidiary obtaining medical device registration certificates issued by the Chongqing Drug Administration. It lists specific product registration details and discusses the impact on the company and risk warnings. The document is short (1840 characters) and does not contain financial statements, management discussion, or detailed financial data. It is an announcement of a regulatory or operational update rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-12 Chinese
深圳普门科技股份有限公司关于自愿披露控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Shenzhen Pumen Technology Co., Ltd. regarding the voluntary disclosure of its controlling subsidiary obtaining medical device registration certificates issued by the Chongqing Drug Administration. It lists specific medical device registration certificates, their validity, and intended use. The document also discusses the impact on the company and includes a risk warning. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is an announcement of a regulatory or operational update related to product registration, not a financial report or management change. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-01-05 Chinese
深圳普门科技股份有限公司关于2021、2022年股票期权激励计划2023年第四季度自主行权结果暨股份变动的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement from Shenzhen Pumen Technology Co., Ltd. regarding the exercise results of stock options under the 2021 and 2022 stock option incentive plans for the fourth quarter of 2023. It includes specifics on the number of shares exercised, the decision-making process, board and supervisory approvals, stock option grant details, and changes in share capital. The document is an official announcement about stock option exercises and related share capital changes, including information on the source of shares and the impact on shareholding structure. It does not contain financial statements or comprehensive financial performance data, nor is it a transcript, presentation, or legal proceeding report. It is not a report publication announcement since it contains substantive details rather than just a notice of report availability. The content fits best under the category of Transaction in Own Shares (POS), as it reports on the company's stock option exercises and resulting share issuance and shareholding changes.
2024-01-03 Chinese
深圳普门科技股份有限公司关于变更对外投资项目的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Shenzhen Pumen Technology Co., Ltd. regarding a change in an external investment project. It details the change in project name, location, investment amount, and related agreements. The document includes risk disclosures and confirms that the investment is not a related-party transaction or a major asset restructuring. It is a formal announcement of a corporate investment decision and project update, not a financial report, earnings release, or management discussion. The document length is 4081 characters, which is relatively short and focused on a specific corporate action. This fits the category of a Capital/Financing Update (CAP), as it concerns changes in investment projects and capital deployment plans. It is not an announcement of voting results, board changes, or legal proceedings, nor is it a report publication or regulatory filing. Therefore, the best classification is CAP with high confidence.
2023-12-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.